Optimizing autologous stem cell collections for patients with multiple myeloma receiving G‐CSF and Plerixafor: A single center project
Journal of Clinical Apheresis · 2024
DOI: 10.1002/jca.22127 ↗At a glance
Journal article in Journal of Clinical Apheresis, 2024. Written by Ayda Javanbakht and 11 co-authors. Institution: Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia…. Major MEDLINE topics: Multiple Myeloma, Cyclams, Benzylamines, Granulocyte Colony-Stimulating Factor. 26 references.
Abstract (original language)
Background
Increasing indications for cellular therapy collections have stressed our healthcare system, with autologous collections having a longer than desired wait time until apheresis collection. This quality improvement initiative was undertaken to accommodate more patients within existing resources. Study Design and Methods Patients with multiple myeloma who underwent autologous peripheral blood stem cell collection from October 2022 to April 2023 were included. Demographic, mobilization, laboratory, and apheresis data were retrospectively collected from the medical record.
Results
This cohort included 120 patients (49.2% male), with a median age of 60 years. All received G‐CSF and 95% received pre‐emptive Plerixafor approximately 18 hours pre‐collection. Most (79%) had collection goals of at least 8 × 10 6 /kg CD34 cells, with 63% over 70 years old having this high collection goal (despite 20 years of institutional data showing
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Center for Transfusion and Cellular Therapies, Emory Healthcare, Atlanta, Georgia, USA.
- Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
ORCID profiles: Ayda Javanbakht, Stephanie Stringer, Edmund K Waller, Nisha Joseph, John D Roback, Thomas Schneider, H Cliff Sullivan, Jeanne E Hendrickson
Cite
APA
Javanbakht, A., Stringer, S., Anderson, H., Hamilton, E., Philip, A., Waller, E. K., Langston, A. A., Joseph, N., Roback, J. D., Schneider, T., Sullivan, H. C., & Hendrickson, J. E. (2024). Optimizing autologous stem cell collections for patients with multiple myeloma receiving G‐CSF and Plerixafor: A single center project. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.22127
Vancouver
Javanbakht A, Stringer S, Anderson H, Hamilton E, Philip A, Waller EK, et al. Optimizing autologous stem cell collections for patients with multiple myeloma receiving G‐CSF and Plerixafor: A single center project. Journal of Clinical Apheresis. 2024. doi:10.1002/jca.22127
BibTeX
@article{Javanbakht2024,
author = {Javanbakht, Ayda and Stringer, Stephanie and Anderson, Hollie and Hamilton, Ellie and Philip, Anisha and Waller, Edmund K and Langston, Amelia A and Joseph, Nisha and Roback, John D and Schneider, Thomas and Sullivan, H Cliff and Hendrickson, Jeanne E},
title = {Optimizing autologous stem cell collections for patients with multiple myeloma receiving G‐CSF and Plerixafor: A single center project},
journal = {Journal of Clinical Apheresis},
year = {2024},
doi = {10.1002/jca.22127}
}
EUVIMED